Third in a three-part series
Chip Parkinson, CEO, Gifthealth
Advertisement
Articles by Chip Parkinson, CEO, Gifthealth
Second in a three-part series. Next up: The DTP Balance Sheet - Access Up, Friction Down
First in a three-part series. Next up: what is DTP and who benefits from it?
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Lilly’s Orforglipron, Retatrutide Named as Defining GLP-1 Drugs of the Next Decade
2
Roundup: Pharma’s Funding Surge Ahead of J.P. Morgan 2026
3
Johnson & Johnson Reaches Agreement with Trump Administration, Continues $55 Billion US-Based Investment Plan
4
Taming the Complexity of CGT Commercialization: 5 Keys to a Workable Operating Model
5